Health Care Reform
Under Obamacare, premiums and deductibles are skyrocketing, insurers are fleeing the health care exchanges and people are left with a health care system that doesn’t work for them and their families. Obamacare is failing, and that’s why the House acted to pass the American Health Care Act (AHCA). This legislation repeals Obamacare, restores competition and choice to the health care marketplace and lowers insurance premiums. The AHCA ensures that no one can be denied coverage, including people with pre-existing conditions. In addition, no-one, regardless of health status, will be charged higher premiums if they maintain their coverage. Finally, this bill prohibits insurers from rescinding coverage based on a pre-existing condition. The AHCA must now be considered by the Senate. To read more about the AHCA, click here.
In 2017, Rep. Debbie Wasserman Schultz (D-FL) and I introduced H.R. 2307, the Protecting Access to Lifesaving Screenings Act (PALS Act). The PALS Act would postpone recent United States Preventative Services Task Force (USPSTF) recommendations that could severely limit women’s access to mammograms, especially for women younger than 49 years old. Recently drafted recommendations from the USPSTF gave annual mammograms for women ages 40-49 a “C” rating, meaning that there is at least a moderate certainty that the net benefit of the procedure is small and that the screenings should be performed only selectively. The proposed recommendations also state that women 50-74 need mammograms only every other year. The USPSTF’s drafted recommendations could limit critical access to lifesaving breast exams for millions of women because insurance companies would no longer be required to fully cover mammograms for women younger than 49 years old. The PALS Act would postpone the USPSTF recommendations for two years and allow Congress to review concerns about the USPSTF and the impact these recommendations would have on women being screened for cancer.
In addition to making common sense health care reforms to lower healthcare costs, increase accessibility and improve the quality of care, we must also ensure that we continue to drive innovation and research into the next generation of treatments and cures. We made progress with the 21st Century Cures Act, which was signed into law in 2016. It is an innovation game-changer that accelerates the discovery, development, and delivery of safe cures and treatments for families across the country, and keeps the United States on the cutting edge of medical innovation.
As part of 21st Century Cures, H.R. 3299, the Strengthening Public Health Emergency Response Act, was signed into law. I introduced this legislation with Rep. Anna Eschoo (D-CA) to improve U.S. biodefense efforts and incentivize the development of vaccines for dangerous and deadly pathogens as identified by the Department of Homeland Security. Read more about my efforts to strengthen U.S. biodefense here.
At the same time, $1 billion was included in 21st Century Cures to address the heroin and opioid abuse crisis and support programs and grants signed into law as part of the Comprehensive Addiction and Recovery Act (CARA). To read more about CARA and efforts to address substance abuse click here.
In addition, 21st Century Cures made great strides to reform our mental healthcare system to improve care for those with mental illness, strengthen our nation’s mental health workforce, and ensure communication between providers, families and patients. To read more about efforts to improve mental health care and end the stigma associated with mental illness, click here.
To read an op-ed I co-authored with six other members of the Indiana Congressional Delegation about healthcare reform, click here.
To read an op-ed I wrote about how 21st Century Cures will help people get the treatment and care they need, click here.
To watch my floor statement about potential for 21st Century Cures to save lives, like my dear friend Judy Warren who passed away from pancreatic cancer in 2015, click here. For more information on the 21st Century Cures act, click here.
More on Health Care Reform
Insufficient stockpiles and a lack of personal protective equipment during the COVID-19 pandemic should serve as a warning for America on future preparedness, Rep. Susan Brooks (R-Ind.) said at an Axios virtual event on Friday.
What they're saying: "Congress had been beefing up for years — the appropriations for preparedness — it certainly was not enough, and we recognize that," Brooks said.
On Friday September 18, Axios' Margaret Talev hosted a conversation on the 2020 election, exploring the Trump and Biden administrations' positions on everything from health care to economics to the coronavirus response, featuring Rep. Ro Khanna and Rep. Susan Brooks.
U.S. Reps. Susan Brooks (R-IN) and Fred Upton (R-MI) on July 15 introduced bipartisan legislation to ramp up and expand America’s Strategic National Stockpile.
The U.S. House Energy and Commerce Committee the same day marked up and passed the measure, the Strengthening America’s Strategic National Stockpile Act of 2020, H.R. 7574, which is sponsored by U.S. Rep. Elissa Slotkin (D-MI) and 18 original cosponsors, including Reps. Brooks, Upton, Buddy Carter (R-GA), Jackie Walorski (R-IN), and Michael Burgess (R-TX). The bill now heads to the House for consideration.
Congresswomen Susan W. Brooks (R-IN05) and Elissa Slotkin (D-MI08) led a group of bipartisan lawmakers in introducing the Strengthening America’s Strategic National Stockpile Act, which passed the House Energy and Commerce Committee unanimously today. This major bipartisan package the House will consider will make substantial improvements to our nation’s Strategic National Stockpile while reducing America’s dependence on foreign sources of critical medical supplies.
WASHINGTON, DC – Congresswomen Susan W. Brooks (R-IN05) and Elissa Slotkin (D-MI08) led a group of bipartisan lawmakers in introducing the Strengthening America’s Strategic National Stockpile Act, which passed the House Energy and Commerce Committee unanimously today. This major bipartisan package the House will consider will make substantial improvements to our nation’s Strategic National Stockpile while reducing America’s dependence on foreign sources of critical medical supplies.
U.S. Rep. Susan Brooks (R-IN) on Feb. 21 introduced a bipartisan resolution recognizing the Global Alliance for Vaccines and Immunizations (GAVI).
“We must continue to fund this crucial alliance to prevent illnesses, which not only keeps our children healthy and safe but delivers economic benefits globally,” Rep. Brooks said.
WASHINGTON, DC – Congresswoman Susan Brooks (IN-05) and Congresswoman Betty McCollum (MN-04), Co-Chairs of the Global Health Caucus, have introduced a resolution in support of the live-saving work of the Global Alliance for Vaccines and Immunizations (GAVI). H.Res.861 highlights GAVI’s twenty years of success in saving the lives of children in the world’s poorest countries by improving access to new and underutilized vaccines. Since 2000, 760 million children have received immunizations, preventing the deaths of more than 13 million people.
Washington, D.C.-Today, Congresswoman Susan Brooks (IN-05), along with Representatives Greg Gianforte (MT- At Large), Lisa Blunt Rochester (DE- At Large), Congressman G. K. Butterfield (NC-01), and Robin Kelly (IL-02), introduced the Data Mapping to Save Moms’ Lives Act. The bill will use data mapping to identify areas of the country where high rates of poor maternal health overlap with a lack of broadband access.
WASHINGTON, DC – Today Congresswoman Susan W. Brooks (R-IN05) provided the following statement after voting against H.R.3:
Congresswoman Susan W. Brooks (R-Ind.-05) joined Members of the Energy and Commerce Committee in introducing H.R. 19, The Lower Costs, More Cures Act, which uses bipartisan reforms to lower out of pocket spending on prescription drugs, protect access to new medicines and cures, strengthen transparency and promote competition.